Cellevate AB
Laura Chirica, PhD has a strong background in the biotech and life science industries. Currently, Laura holds positions on the board of directors at Gradientech AB and SenzaGen, and is a member of the Center Board at AdBIOPRO. Laura also serves as the Chief Executive Officer at Cellevate AB. With their extensive experience in commercial strategy and leadership roles at companies like Euro Diagnostica and GE Healthcare, Laura brings a wealth of knowledge to the development of innovative bioproduction technologies and diagnostics.
Cellevate AB
Cellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3d™ - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3d™ carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing. We offer a range of products based on our versatile and easily functionalized platform for several applications, including next generation cell- and gene therapies. For more information, please visit www.cellevate.com